Liminatus Pharma Inc. (LIMN) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Liminatus Pharma Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$2.92
+1.39% today
Market cap
$4M
Overall quality
—
Kronos AI 30-day
+73.6%
8 of 8 simulated paths end higher
Liminatus Pharma Inc. (LIMN) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $4M. It trades at $2.92, up 1.39% today. Kronos AI's 30-day forecast is +73.6% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
| Expected close | $5.02 (+73.6%) |
| Likely range | +46.8% … +122.0% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.